Thermo Fisher Scientific Inc

S&P 500 Mega-Cap Stocks Blue Chip Stocks Healthcare Stocks Best Dividend Stocks

$542.83

+0.47 (+0.09%)

As of Feb 12, 6:29 PM ET ·

Income Statement

	FY 2026	FY 2026	FY 2025	FY 2025	FY 2025
Revenue	44.29B	44.29B	44.41B	44.41B	90.16B
Net Income	6.66B	6.66B	6.01B	6.01B	9.87B
EPS	—	—	—	—	—
Profit Margin	15.0%	15.0%	14.3%	14.3%	11.0%
Rev Growth	-0.3%	-0.3%	-0.3%	-0.3%	+7.5%

Balance Sheet

	FY 2026	FY 2026	FY 2025	FY 2025	FY 2025
Total Debt	43.28B	43.28B	43.28B	43.28B	92.88B
Total Equity	58.70B	58.70B	58.70B	58.70B	105.77B
D/E Ratio	0.74	0.74	0.74	0.74	0.88

Cash Flow

	FY 2026	FY 2026	FY 2025	FY 2025	FY 2025
EBITDA	9.41B	9.41B	8.96B	8.96B	18.03B
Free Cash Flow	—	—	—	—	15.06B